Cooperative Agreement 72061519CA00007

Federal Grant Award Summary The University of Washington received a $690,538 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 19, 2025, through July 31, 2030. This award supports research focused on expanding access to and improving the delivery of tuberculosis preventive therapy (TPT) in Kenya. The project addresses a documented gap between international...

The U.S. Agency for International Development (USAID) awarded a $2,100,000 Cooperative Agreement under the Foreign Assistance for Programs Overseas (CFDA 98.001) grant program to the National Council of People Living with HIV/AIDS (NACOPHA) in Tanzania. The purpose of this 5-year project is to increase utilization of quality HIV prevention and treatment services by implementing community-led monitoring activities in close collaboration with the Government of Tanzania. The project will...

This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...

FEND-TB Project Grant Summary Rutgers, The State University of New Jersey (RBHS-School of Nursing) received a $3.09 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 10, 2025, with a completion date of August 31, 2030. The grant supports the development and evaluation of tuberculosis (TB) diagnostic tools and drug susceptibility tests (DSTs) through a...

This Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $194,094 in funding to The Johns Hopkins University to investigate the role of tuberculosis (TB) disclosure and stigma in TB care outcomes. The research project, active from June 1, 2026 through May 31, 2028, will deliver comprehensive research findings examining how TB-related stigma influences patient disclosure decisions and impacts the...

This K43 Career Development Award, funded by the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), provides $273,436 in support for research investigating post-tuberculosis lung disease (PTLD) sequelae in pediatric populations in The Gambia. Awarded on September 16, 2025, with a completion date of August 31, 2030, the project is led by Principal Investigator Dr. Esin Nkereuwem at the Medical Research Council Unit The Gambia at the...

The Department of State Bureau of African Affairs awarded a $244,412 project grant to Miscellaneous Foreign Awardees for services supporting the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR) CFDA 19.029 in Kenya. The grant period is from May 16, 2022 to May 31, 2023. As part of the PEPFAR program objective to provide support for HIV/AIDS treatment, care, and prevention in developing countries, the awardee will deliver services focused on HIV/AIDS care and prevention in...

The US Agency for International Development Tanzania awarded a $750,000 cooperative agreement to Save the Children Federation, Inc. to provide oxygen therapy sets and strengthen COVID-19 case management in referral hospitals in Tanzania from July 30, 2021 through May 15, 2022. This award was made under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to support the health sector goals outlined in USAID/Tanzania's 2019-2021 Country Development Cooperation Strategy....

The Department of State Bureau of African Affairs awarded a $389,600 Project Grant to Women Fighting Aids in Kenya from May 16, 2022 to May 31, 2023 under the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR, CFDA 19.029). The grant will support Women Fighting Aids in Kenya's delivery of services to combat HIV/AIDS in Kenya as outlined under the PEPFAR objective of providing support for HIV/AIDS treatment, care, and prevention activities internationally. Based on the program...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...